Literature DB >> 14992729

SUMO promotes HDAC-mediated transcriptional repression.

Shen-Hsi Yang1, Andrew D Sharrocks.   

Abstract

Recently, SUMO modification has been shown to impart repressive properties on several transcriptional regulatory proteins. Indeed, the ETS domain transcription factor Elk-1 is modified by SUMO, and this modification is reversed by ERK MAP kinase pathway activation. This causes a switch from a repressive to activated state. However, the mechanism(s) of SUMO-mediated transcriptional repression is unclear. Here, we have investigated how sumoylation of Elk-1 leads to transcriptional repression. We demonstrate that sumoylation of Elk-1 results in the recruitment of histone deacetylase activity to promoters. In particular, our data point to a key role for HDAC-2. This recruitment leads to decreased histone acetylation and hence transcriptional repression at Elk-1 target genes. Thus, our data demonstrate an important integration point for two protein-modifying pathways in the cell, the SUMO and deacetylation pathways, that combine to promote transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992729     DOI: 10.1016/s1097-2765(04)00060-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  139 in total

1.  SUMO modified proteins localize to the XY body of pachytene spermatocytes.

Authors:  Richard S Rogers; Amy Inselman; Mary Ann Handel; Michael J Matunis
Journal:  Chromosoma       Date:  2004-09-03       Impact factor: 4.316

2.  Coordinated regulation of transcription factor Bcl11b activity in thymocytes by the mitogen-activated protein kinase (MAPK) pathways and protein sumoylation.

Authors:  Ling-juan Zhang; Walter K Vogel; Xiao Liu; Acharawan Topark-Ngarm; Brian L Arbogast; Claudia S Maier; Theresa M Filtz; Mark Leid
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

3.  The CRAL/TRIO and GOLD domain protein TAP-1 regulates RAF-1 activation.

Authors:  Kenneth G Johnson; Kerry Kornfeld
Journal:  Dev Biol       Date:  2010-03-15       Impact factor: 3.582

4.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

5.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

Review 6.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

7.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

8.  Phosphorylation of Williams syndrome transcription factor by MAPK induces a switching between two distinct chromatin remodeling complexes.

Authors:  Hiroyuki Oya; Atsushi Yokoyama; Ikuko Yamaoka; Ryoji Fujiki; Masayoshi Yonezawa; Min-Young Youn; Ichiro Takada; Shigeaki Kato; Hirochika Kitagawa
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

9.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

10.  Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.

Authors:  Jing Song; Linda K Durrin; Thomas A Wilkinson; Theodore G Krontiris; Yuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.